Kidney xenotransplantation: Recent progress in preclinical research

Clin Chim Acta. 2021 Mar:514:15-23. doi: 10.1016/j.cca.2020.11.028. Epub 2020 Dec 7.

Abstract

Kidney transplantation is the most effective treatment for end-stage renal disease, but is limited by the increasing shortage of deceased and living human donor kidneys. Xenotransplantation using pig organs provides the possibility to resolve the issue of organ supply shortage and is regarded as the next great medical revolution. In the past five years, there have been sequential advances toward the prolongation of life-supporting pig kidney xenograft survival in non-human primates, with the longest survival being 499 days. This progress is due to the growing availability of pigs with multi-layered genetic modifications to overcome the pathobiological barriers and the application of a costimulation blockade-based immunosuppressive regimen. These encouraging results bring the hope to initiate the clinical trials of pig kidney transplantation in the near future. In this review, we summarized the latest advances regarding pig kidney xenotransplantation in preclinical models to provide a basis for future investigation and potential clinical translation.

Keywords: Costimulation blockade; Genetic modifications; Kidney xenotransplantation; Non-human primates; Pigs.

Publication types

  • Review

MeSH terms

  • Animals
  • Graft Rejection
  • Heterografts
  • Immunosuppressive Agents
  • Kidney
  • Kidney Transplantation*
  • Swine
  • Transplantation, Heterologous

Substances

  • Immunosuppressive Agents